Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis-Reference-Cited by-同舟云学术

Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis

Published:2018-09-25 Issue:15 Volume:78 Page:1549-1566
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Baldassari Laura E.,Fox Robert J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/article/10.1007/s40265-018-0984-5/fulltext.html

Reference179 articles.

1. National Multiple Sclerosis Society. Frequently asked questions; 2018. https://www.nationalmssociety.org/What-is-MS/Who-Gets-MS . Accessed 18 Mar 2018.

2. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–86. https://doi.org/10.1212/wnl.0000000000000560 .

3. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73. https://doi.org/10.1016/s1474-4422(17)30470-2 .

4. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302. https://doi.org/10.1002/ana.22366 .

5. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338(5):278–85. https://doi.org/10.1056/nejm199801293380502 .

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment;Pharmaceuticals;2024-07-25

2. The Role of Cobalamin in Multiple Sclerosis: An Update;Inflammation;2024-06-21

3. BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair;Acta Neuropathologica;2024-04-24

4. Nestorone (segesterone acetate) effects on neuroregeneration;Frontiers in Neuroendocrinology;2024-04

5. Adherence to disease-modifying therapies among patients with multiple sclerosis in Bulgaria – A real world study;Pharmacia;2024-02-15